Compensation of COVID-19 Testing for Employees
| Instrument „Compensation of COVID-19 Testing for Employees“ have been suspended since 30 June. |
*instrument_consult*:
What is the maximum amount?
Up to EUR 12 per serological antibody test.
Up to EUR 12 for SARS-CoV-2 rapid antigen test.
If the test costs less than EUR 12, it will be reimbursed in full.
The maximum possible sum of compensation (S) per applicant is calculated according to the formula:
S=D x T x K
D – the number of employees planned to participate in COVID-19 testing;
T – the maximum possible number of tests per employee (4 units per month);
K – the maximum reimbursable test price (up to 12 euros).
The maximum amount of compensation may not exceed the de minimis balance of the state aid.
A total of 30 million euros is allocated for compensation of employee testing from the state budget.
Terms
Compensations will be allocated for testing costs incurred from 23 February 2021 to 31 May 2021.
Applications and documents supporting the payment of the tests performed can be submitted from 29 March 2021 to 30 June 2021. The invitation for submission of application may be suspended earlier if the amount allocated to the measure expires.
How does it work?
For compensation, please contact INVEGA and submit your application in the electronic application system.
Required data for filling in the application:
- Company’s information
- Number of employees
- Number of tests performed and planned to be performed to employees
- Requested compensation amount
Important: it will not be possible to change the information on the number of employees entered in the application and the amount of compensation requested at a later stage.
Evaluation of applications and payment of compensation
Applications shall be evaluated in the order of their submission to INVEGA.
The application shall be evaluated within 10 business days from the day of submission of the duly completed application and documents to INVEGA. In the event of a large flow of applications or due to technical obstacles, the deadline for the evaluation of applications may be extended, however no more than for 10 business days.
The costs of COVID-19 tests shall be reimbursed to the applicant once a month – before the 25th day of the month following the reporting month. The calculated compensation to the applicant shall be transferred to the account specified in the application.
As required by law, INVEGA will randomly screen at least five percent of applicants who have passed a positive decision. The inspections will be carried out in accordance with the procedure approved by the CEO of INVEGA.
Testing scheme
It is important to order tests for employees on a regular basis: the antibody test shall be carried out at intervals of no more than 60 days and the antigen test shall be carried out at intervals of no more than 7 days and at least every 10 days.
The serological antibody test, which detects anti-S, anti-S1 or anti-RBD IgG antibodies to SARS-CoV-2, indicates whether a person has had the coronavirus.
SARS-CoV-2 rapid antigen test shows if a person is currently carrying the coronavirus.